The role of long non-coding RNA BCAR4 in human cancers

被引：9
|
作者：
Yi, Qiong [1 ,2 ,3 ]
Liu, Zhongcheng [1 ,2 ,3 ]
Zhang, Kun [1 ,2 ,3 ]
Liu, Xuening [1 ,2 ,3 ]
Wang, Lifu [1 ,2 ,3 ]
Geng, Bin [1 ,2 ,3 ]
Xia, Yayi [1 ,2 ,3 ]
机构：
[1] Lanzhou Univ, Hosp 2, Dept Orthopaed, Lanzhou 730000, Gansu, Peoples R China
[2] Orthopaed Key Lab Gansu Prov, Lanzhou 730000, Gansu, Peoples R China
[3] Orthopaed Clin Med Res Ctr Gansu Prov, Lanzhou 730000, Gansu, Peoples R China
来源：
HUMAN CELL | 2021年 / 34卷 / 05期
基金：
中国国家自然科学基金;
关键词：
lncRNA; BCAR4; Cancer; Biomarker; Mechanism; BREAST-CANCER; CELL-PROLIFERATION; GASTRIC-CANCER; ANTIESTROGEN RESISTANCE; PROMOTES PROLIFERATION; TAMOXIFEN RESISTANCE; POOR-PROGNOSIS; LNCRNA BCAR4; STEM-CELLS; OSTEOSARCOMA;
D O I：
10.1007/s13577-021-00556-6
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
Long non-coding RNA (lncRNA) is a type of non-coding RNA with length of nucleotides > 200 bp. Increasing evidences show that lncRNA breast cancer antiestrogen resistance 4 (BCAR4) plays an important role in the occurrence and development of various human cancers. It is found that BCAR4 is highly expressed in diverse tumor tissues and cells, and the high expression of BCAR4 is usually associated with poor prognosis. BCAR4 is considered as an oncogene in human cancers. By competing endogenous RNA (ceRNA) mechanism and regulating different signaling pathways, BCAR4 participates in the proliferation, apoptosis, migration, invasion, epithelial-mesenchymal transition (EMT), metastasis and tumorigenesis of different cancers. In addition, overexpression of BCAR4 promotes drug resistance of tumor cells. Therefore, BCAR4 is a promising biomarker for cancer diagnosis and prognosis, and it is a potential target for cancer therapy. This paper reviews studies focusing on the relationship between BCAR4 and cancers in recent years and aims to summarize the effect and mechanism of BCAR4 in human cancers.
引用
收藏
页码：1301 / 1309
页数：9
相关论文
共 50 条
  • [21] The functional role of long non-coding RNA in human carcinomas
    Gibb, Ewan A.
    Brown, Carolyn J.
    Lam, Wan L.
    MOLECULAR CANCER, 2011, 10
  • [22] CRNDE: an oncogenic long non-coding RNA in cancers
    Lu, Ya
    Sha, Huanhuan
    Sun, Xun
    Zhang, Yuan
    Wu, Yang
    Zhang, Junying
    Zhang, Hui
    Wu, Jianzhong
    Feng, Jifeng
    CANCER CELL INTERNATIONAL, 2020, 20 (01)
  • [23] CRNDE: an oncogenic long non-coding RNA in cancers
    Ya Lu
    Huanhuan Sha
    Xun Sun
    Yuan Zhang
    Yang Wu
    Junying Zhang
    Hui Zhang
    Jianzhong Wu
    Jifeng Feng
    Cancer Cell International, 20
  • [24] The functional role of long non-coding RNA in human carcinomas
    Ewan A Gibb
    Carolyn J Brown
    Wan L Lam
    Molecular Cancer, 10
  • [25] Long Non-coding RNA DANCR as an Emerging Therapeutic Target in Human Cancers
    Jin, Shi-Jia
    Jin, Ming-Zhu
    Xia, Bai-Rong
    Jin, Wei-Lin
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [26] ANRIL: a pivotal tumor suppressor long non-coding RNA in human cancers
    Li, Zheng
    Yu, Xin
    Shen, Jianxiong
    TUMOR BIOLOGY, 2016, 37 (05) : 5657 - 5661
  • [27] Long Non-coding RNA ANRIL and Polycomb in Human Cancers and Cardiovascular Disease
    Aguilo, Francesca
    Di Cecilia, Serena
    Walsh, Martin J.
    LONG NON-CODING RNAS IN HUMAN DISEASE, 2016, 394 : 29 - 39
  • [28] Targeting long non-coding RNA as a novel treatment option in human cancers
    Kondo, Yutaka
    CANCER SCIENCE, 2018, 109 : 346 - 346
  • [29] The different prognostic value of long non-coding RNA BANCR in human cancers
    Hu, Linhui
    Li, Manman
    Pu, Lianfang
    Ding, Yangyang
    Liu, Jun
    Xiong, Shudao
    MINERVA MEDICA, 2017, 108 (01) : 97 - 101
  • [30] Expression and crucial role of long non-coding RNA FGD5-AS1 in human cancers
    Zhu, Lixu
    Shi, Xiaoyi
    Yu, Xiao
    Wang, Zhihui
    Zhang, Menggang
    He, Yuting
    Guo, Wenzhi
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (10): : 10964 - 10976
12345